Geographic evidence hub
Published infectious-disease research classified with a high-confidence geographic relationship to Switzerland.
Evidence stream
5 publications
Nature Communications
Why it matters nowEnvironmental monitoring programs could utilize this analytical approach to maintain continuous epidemiological tracking in areas where traditional clinical reporting is incomplete or resource-constrained.
Eurosurveillance
Why it matters nowThe findings support vaccination recommendations by demonstrating that even young children can experience severe TBE and that complete vaccination provides durable protection against neurological disease for at least 10 years.
Epidemics
Why it matters nowThe findings indicate that cross-border-associated cases were an important component of the modeled Swiss epidemic dynamics during the studied summer periods. The abstract states that understanding this contribution may inform future surveillance strategies.
Eurosurveillance
Why it matters nowThe findings support the potential use of targeted digital PCR in wastewater to monitor variant frequency and may indicate changes earlier than clinical sequencing. The evidence presented is specific to the reported Zurich analysis and does not establish performance in other settings.
The Lancet Infectious Diseases
Why it matters nowThe paper is relevant to Ebola vaccine development because it provides early human safety and immune-response data for a candidate vaccine during an outbreak context. It is positioned as evidence to support later-phase efficacy studies rather than as a population-level effectiveness assessment.
